Hjem › Graft-versus-host-sygdom › Pennsylvania
Graft-versus-host-sygdom kliniske forsøg i Pennsylvania
6 studier for Graft-versus-host-sygdom søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
- UMPC Hillman Cancer Center, Pittsburgh
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07565220A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
RekruttererFase 2
Alder 2 og opefter · Alle køn · Opdateret 16. jun. 2026 · NCT04710576A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
- University of Pittsburgh Medical Center (Data Collection Only), Pittsburgh
RekruttererFase 2
Alder 4 og opefter · Alle køn · Opdateret 22. maj 2026 · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Pennsylvania, Philadelphia
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. maj 2026 · NCT06615050Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
- Penn State Cancer Institute, Hershey
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. apr. 2026 · NCT06926595A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- UPMC Hillman Cancer Center, Pittsburgh
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT06619561Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.